-
Mashup Score: 18Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Data Capture with nCartes: A Leap Day Opportunity | SWOG - 3 month(s) ago
For more than a decade, SWOG has been working to find a way for sites to access these EHR data more efficiently, while also improving data quality. In May of 2022, I wrote of our pilot project with cloud software provider nCartes, Inc., developing and implementing an EHR-to-EDC solution to make this data transfer process more efficient for our member sites.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: Data Capture with nCartes: A Leap Day Opportunity In our @SWOG-nCartes system, data from the electronic health record are automatically fed to the software, reviewed by study coordinators, then passed directly to case report forms. https://t.co/OadjAwmQPX https://t.co/h7V0CJZrgn
-
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Adding the Drugs Tazemetostat or Zanubrutinib to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Previous Treatment | SWOG - 3 month(s) ago
Clinical Trial Summary (S2207) What is the purpose of this clinical trial? This study is for people with certain types of large B-cell lymphoma (LBCL). It will test 2 study drugs for treating lymphoma that came back or did not respond to previous treatment. Researchers will test adding each study drug to a usual…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Study S2207 is for people with large B-cell #lymphoma that came back or didn’t respond to previous treatment. It asks if adding either of the drugs tazemetostat or zanubrutinib to usual treatment can help patients. Learn more at https://t.co/RXxA5bRM3x. Or call 1-800-4-CANCER. https://t.co/OIILZ96xMq
-
S2210 is a study for people with #prostatecancer who have an inherited BRCA1 or BRCA2 gene mutation. It tests treatment before surgery using the #chemo drug carboplatin. Learn more at https://t.co/apJjvub0vU. Or call 1-800-4-CANCER. Ask about S2210. #pcsm #urology https://t.co/WhZ3CtlKvd